Bhaumik Patel is an Oncology physician affiliated with Virginia Commonwealth University. OpenAlex indexes 33 publications with 244 citations (h-index 8); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1201 Broad Rock Blvd
Richmond, VA 232244915
Telephone
804-675-5000Registry record last updated 29 Mar 2012.
Clinical trials
- Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
Sponsor: Barbara Ann Karmanos Cancer Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Intera Oncology, IncProgram year20251 payment
- Eisai Inc.Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
52.4%Serotonin-3 Receptor Antagonist31.7%Ondansetron Hcl100%Part D≥14 patientsCorticosteroid20.6%Prednisone100%Part D<11 patientsNervous system
30.2%Phenothiazine30.2%Prochlorperazine Maleate100%Part D≥13 patientsSensory organs
17.5%Corticosteroid17.5%Dexamethasone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2013–2025 per NIH RePORTER. The latest:
- StarD5, a protein that translocates cholesterol to the plasma membrane, is a novel target for Colon Cancer
Va Veterans Administration Hospital
FY2025I01BX000837 - Unique Non-Saccharide Mimetics of Sulfated Glycosaminoglycan Target Colon Cancer Stem Cells
Va Veterans Administration Hospital
FY2025I01BX004584 - StarD5, a protein that translocates cholesterol to the plasma membrane, is a novel target for Colon Cancer
Va Veterans Administration Hospital
FY2024I01BX000837
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cranberry: A Promising Natural Product for Animal Health and Performance
Current Issues in Molecular Biology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Jasmohan Bajaj, MD
Virginia Commonwealth University
Velimir Luketic, MD
Virginia Commonwealth University
Patrick Ching, MD, MPH
Virginia Commonwealth University
Robert Delorenzo, MD
Virginia Commonwealth University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”